Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|April 14, 2022
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic DysfunctionGiulia Ponterio, Gaia Faustini, Ilham El Atiallah, et al.
Cells|December 11, 2022
Synapsin III Regulates Dopaminergic Neuron Development in VertebratesGaia Faustini, Francesca Longhena, Alessia Muscò, et al.
Brain Pathology (Zurich, Switzerland)|January 14, 2018
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brainsFrancesca Longhena, Gaia Faustini, Tatiana Varanita, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 17, 2022
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeGaia Faustini, Francesca Longhena, Anna Masato, et al.
Neurobiology of Disease|February 8, 2020
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateGaia Faustini, Francesca Longhena, Agostino Bruno, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 11, 2026
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinomaMariangela Tamburello, Andrea Abate, Caterina Boldini, et al.
Journal of Neuroinflammation|February 17, 2022
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's diseaseAdrianne F Pike, Francesca Longhena, Gaia Faustini, et al.
Glia|October 12, 2020
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytesAlice Filippini, Veronica Mutti, Gaia Faustini, et al.
NPJ Parkinson'S Disease|March 25, 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's diseaseAnna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
Pageof 4